Barclays
PRAH

Barclays’s PRA Health Sciences, Inc. PRAH Stock Holding History

Barclays’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8,400
Closed -$784K – 7547
2018
Q2 		$784K Buy
+8,400
New +$723K ﹤0.01% 3529

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Barclays's PRAH Position: Q3 2021 in Review

Barclays sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,005,836 shares — an estimated $166M sold.

Barclays first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $166M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Barclays reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Barclays sold 1,005,836 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $166M.
  • Barclays first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
  • Barclays's PRA Health Sciences, Inc. position peaked at $166M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.